Your browser doesn't support javascript.
loading
Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer.
Müller-Stich, B P; Probst, P; Nienhüser, H; Fazeli, S; Senft, J; Kalkum, E; Heger, P; Warschkow, R; Nickel, F; Billeter, A T; Grimminger, P P; Gutschow, C; Dabakuyo-Yonli, T S; Piessen, G; Paireder, M; Schoppmann, S F; van der Peet, D L; Cuesta, M A; van der Sluis, P; van Hillegersberg, R; Hölscher, A H; Diener, M K; Schmidt, T.
Afiliação
  • Müller-Stich BP; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Probst P; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Nienhüser H; The Study Center of the German Surgical Society (SDGC), Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Fazeli S; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Senft J; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Kalkum E; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Heger P; The Study Center of the German Surgical Society (SDGC), Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Warschkow R; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Nickel F; The Study Center of the German Surgical Society (SDGC), Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Billeter AT; Department of Surgery, Kantonsspital, St. Gallen, Switzerland.
  • Grimminger PP; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Gutschow C; Department of General, Visceral and Transplant Surgery, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.
  • Dabakuyo-Yonli TS; Department of General, Visceral and Transplant Surgery, Johannes Gutenberg University, Mainz, Germany.
  • Piessen G; Department of Visceral and Transplant Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Paireder M; Epidemiology and Quality of Life Unit, INSERM 1231, Centre Georges François Leclerc, Dijon, France.
  • Schoppmann SF; Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France.
  • van der Peet DL; Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Cuesta MA; Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • van der Sluis P; Gastrointestinal and Minimally Invasive Surgery, Vrije University Medical Centre, Amsterdam, the Netherlands.
  • van Hillegersberg R; Gastrointestinal and Minimally Invasive Surgery, Vrije University Medical Centre, Amsterdam, the Netherlands.
  • Hölscher AH; Department of Surgical Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Diener MK; Department of Surgical Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Schmidt T; Contilia Centre for Oesophageal Diseases, Elisabeth Hospital, Essen, Germany.
Br J Surg ; 108(9): 1026-1033, 2021 09 27.
Article em En | MEDLINE | ID: mdl-34491293
ABSTRACT

BACKGROUND:

Minimally invasive oesophagectomy (MIO) for oesophageal cancer may reduce surgical complications compared with open oesophagectomy. MIO is, however, technically challenging and may impair optimal oncological resection. The aim of the present study was to assess if MIO for cancer is beneficial.

METHODS:

A systematic literature search in MEDLINE, Web of Science and CENTRAL was performed and randomized controlled trials (RCTs) comparing MIO with open oesophagectomy were included in a meta-analysis. Survival was analysed using individual patient data. Random-effects model was used for pooled estimates of perioperative effects.

RESULTS:

Among 3219 articles, six RCTs were identified including 822 patients. Three-year overall survival (56 (95 per cent c.i. 49 to 62) per cent for MIO versus 52 (95 per cent c.i. 44 to 60) per cent for open; P = 0.54) and disease-free survival (54 (95 per cent c.i. 47 to 61) per cent versus 50 (95 per cent c.i. 42 to 58) per cent; P = 0.38) were comparable. Overall complication rate was lower for MIO (odds ratio 0.33 (95 per cent c.i. 0.20 to 0.53); P < 0.010) mainly due to fewer pulmonary complications (OR 0.44 (95 per cent c.i. 0.27 to 0.72); P < 0.010), including pneumonia (OR 0.41 (95 per cent c.i. 0.22 to 0.77); P < 0.010).

CONCLUSION:

MIO for cancer is associated with a lower risk of postoperative complications compared with open resection. Overall and disease-free survival are comparable for the two techniques. LAY

SUMMARY:

Oesophagectomy for cancer is associated with a high risk of complications. A minimally invasive approach might be less traumatic, leading to fewer complications and may also improve oncological outcome. A meta-analysis of randomized controlled trials comparing minimally invasive to open oesophagectomy was performed. The analysis showed that the minimally invasive approach led to fewer postoperative complications, in particular, fewer pulmonary complications. Survival after surgery was comparable for the two techniques.
Oesophagectomy for cancer is associated with a high risk of complications. A minimally invasive approach might be less traumatic, leading to fewer complications and may also improve oncological outcome. A meta-analysis of randomized controlled trials comparing minimally invasive to open oesophagectomy was performed. The analysis showed that the minimally invasive approach led to fewer postoperative complications, in particular, fewer pulmonary complications. Survival after surgery was comparable for the two techniques.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Ensaios Clínicos Controlados Aleatórios como Assunto / Esofagectomia / Procedimentos Cirúrgicos Minimamente Invasivos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Ensaios Clínicos Controlados Aleatórios como Assunto / Esofagectomia / Procedimentos Cirúrgicos Minimamente Invasivos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha